For years, Phreesia, Inc. (NYSE: PHR) has seen its stock price struggle. Those challenges have come at no fault of its own other, but rather as a consequence of its growth, which has been funded by share counts and debt. As the company has continued to gobble up new technology while expanding its reach and offerings, share counts have risen significantly since 2024. And despite the stock losing nearly 50% in Q1 2026, the story for Q2 is that the market capitulated after Phreesia's 2026 guidance update, providing a deep value opportunity in a quality tech speculation.
Phreesia provides automated patient intake services for healthcare providers, grows at a robust pace, and makes money. A shift to profitability underpins the stock price outlook, providing a visible value for investors.
